Filing Details

Accession Number:
0001062993-23-015315
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-07-25 17:27:42
Reporting Period:
2023-07-21
Accepted Time:
2023-07-25 17:27:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
842023 Bio-Techne Corp TECH Biological Products, (No Disgnostic Substances) (2836) 411427402
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1534980 R. Charles Kummeth 614 Mckinley Place Ne
Minneapolis MN 55413
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-07-21 80,000 $88.36 1,258,766 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 400 Indirect By Step-Son
Common Stock 400 Indirect By Step-Daughter
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $31.26 2024-08-09 779,084 779,084 Direct
Common Stock Stock Options (Right to Buy) $44.33 2025-08-08 361,336 361,336 Direct
Common Stock Stock Options (Right to Buy) $44.33 2025-08-08 240,888 240,888 Direct
Common Stock Stock Options (Right to Buy) $47.60 2026-08-07 342,900 342,900 Direct
Common Stock Restricted Stock Units $0.00 52,900 52,900 Direct
Common Stock Stock Options (Right to Buy) $47.60 2026-08-07 228,600 228,600 Direct
Common Stock Restricted Stock Units $0.00 51,516 51,516 Direct
Common Stock Stock Options (Right to Buy) $66.97 2027-08-05 299,768 299,768 Direct
Common Stock Stock Options (Right to Buy) $66.97 2027-08-05 153,180 153,180 Direct
Common Stock Stock Options (Right to Buy) $66.97 2027-08-05 66,600 66,600 Direct
Common Stock Stock Options (Right to Buy) $66.97 2027-08-05 66,600 66,600 Direct
Common Stock Restricted Stock Units $0.00 32,064 32,064 Direct
Common Stock Stock Options (Right to Buy) $120.46 2028-08-06 125,260 125,260 Direct
Common Stock Stock Options (Right to Buy) $120.46 2028-08-06 83,504 83,504 Direct
Common Stock Stock Options (Right to Buy) $94.52 2029-08-15 1,200,000 1,200,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-08-09 779,084 779,084 Direct
2025-08-08 361,336 361,336 Direct
2025-08-08 240,888 240,888 Direct
2026-08-07 342,900 342,900 Direct
52,900 52,900 Direct
2026-08-07 228,600 228,600 Direct
51,516 51,516 Direct
2027-08-05 299,768 299,768 Direct
2027-08-05 153,180 153,180 Direct
2027-08-05 66,600 66,600 Direct
2027-08-05 66,600 66,600 Direct
32,064 32,064 Direct
2028-08-06 125,260 125,260 Direct
2028-08-06 83,504 83,504 Direct
2029-08-15 1,200,000 1,200,000 Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.00 to $88.95 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Includes (i) 11,448 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 14,248 shares of restricted stock for which the risk of forfeiture will lapse as to 7,128 shares on each of August 6, 2023 and August 6, 2024.
  4. Fully exercisable.
  5. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
  6. 17,632 shares vest on each of 8/15/2023 and 8/15/2025, and 17,636 shares vest on 8/15/2024.
  7. Options to purchase 57,152 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 57,148 shares vest on each of 8/7/2022 and 8/7/2023.
  8. Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  9. Options to purchase 38,292 shares vest on 8/5/21 and options to purchase 38,296 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
  10. Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
  11. Options to purchase 22,200 shares vest on each of 8/5/21, 8/5/22 and 8/5/23.
  12. Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
  13. Options to purchase 20,876 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
  14. 600,000 options vest in full or in part on 7/1/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator), and 600,000 options vest in full or in part on 7/1/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).